Bristol Myers reveals a pair of Phase 3 wins for fibrosis, RayzeBio drugs
Bristol Myers Squibb reported two Phase 3 successes on Monday morning, including for an experimental drug that recently ran into safety issues. A trial testing the lung disease program admilparant succeeded ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.